Literature DB >> 16574752

Transplanted embryonic stem cells successfully survive, proliferate, and migrate to damaged regions of the mouse brain.

Anand S Srivastava1, Steve Shenouda, Rangnath Mishra, Ewa Carrier.   

Abstract

An understanding of feasibility of implanting embryonic stem cells (ESCs), their behavior of migration in response to lesions induced in brain tissues, and the mechanism of their in vivo differentiation into neighboring neural cells is essential for developing and refining ESC transplantation strategies for repairing damages in the nervous system, as well as for understanding the molecular mechanism underlying neurogenesis. We hypothesized that damaged neural tissues offer a niche to which injected ESCs can migrate and differentiate into the neural cells. We inflicted damage in the murine (C57BL/6) brain by injecting phosphate-buffered saline into the left frontal and right caudal regions and confirmed neural damage by histochemistry. Enhanced yellow fluorescent protein-expressing ESCs were injected into the nondamaged left caudal portion of the brain. Using immunohistochemistry and fluorescent microscopy, we observed migration of ESCs from the injection site (left caudal) to the damaged site (right caudal and left frontal). Survival of the injected ESCs was confirmed by the real-time polymerase chain reaction analysis of stemness genes such as Oct4, Sox2, and FGF4. The portions of the damaged neural tissues containing ESCs demonstrated a fourfold increase in expression of these genes after 1 week of injection in comparison with the noninjected ESC murine brain, suggesting proliferation. An increased level of platelet-derived growth factor receptor demonstrated that ESCs responded to damaged neural tissues, migrated to the damaged site of the brain, and proliferated. These results demonstrate that undifferentiated ESCs migrate to the damaged regions of brain tissue, engraft, and proliferate. Thus, damaged brain tissue provides a niche that attracts ESCs to migrate and proliferate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574752     DOI: 10.1634/stemcells.2005-0531

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  7 in total

1.  Guided migration of neural stem cells derived from human embryonic stem cells by an electric field.

Authors:  Jun-Feng Feng; Jing Liu; Xiu-Zhen Zhang; Lei Zhang; Ji-Yao Jiang; Jan Nolta; Min Zhao
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

2.  Survival and engraftment of mouse embryonic stem cells in the mammary gland.

Authors:  Hai-Jun Huang; Qi-Shuang Gao; Yun-Guo Qian; Yu-Dan Zhang; Jian Peng; Si-Wen Jiang; Ben Hause
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-12-07       Impact factor: 2.416

Review 3.  Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas.

Authors:  Prakash Rath; Huidong Shi; Joel A Maruniak; N Scott Litofsky; Bernard L Maria; Mark D Kirk
Journal:  Curr Stem Cell Res Ther       Date:  2009-01       Impact factor: 3.828

4.  In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.

Authors:  Mahmud Uzzaman; Gordon Keller; Isabelle M Germano
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

Review 5.  Neural tissue engineering using embryonic and induced pluripotent stem cells.

Authors:  Stephanie M Willerth
Journal:  Stem Cell Res Ther       Date:  2011-04-15       Impact factor: 6.832

6.  Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke.

Authors:  Sung Ung Moon; Jihee Kim; Kiran Kumar Bokara; Jong Youl Kim; Dongwoo Khang; Thomas J Webster; Jong Eun Lee
Journal:  Int J Nanomedicine       Date:  2012-06-01

Review 7.  Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy.

Authors:  Rangnath Mishra; Punita Dhawan; Anand S Srivastava; Amar B Singh
Journal:  World J Stem Cells       Date:  2020-10-26       Impact factor: 5.326

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.